journal article·2018-09

Transfection of gene regulation nanoparticles complexed with pDNA and shRNA controls multilineage differentiation of hMSCs

Hye Jin Kim, Se Won Yi, Hyun Jyung Oh, Jung Sun Lee, Ji Sun Park, Keun-Hong Park

Biomaterials· Volume 177
Publisher page

Abstract

Overexpression and knockdown of specific proteins can control stem cell differentiation for therapeutic purposes. In this study, we fabricated RUNX2, SOX9, and C/EBPα plasmid DNAs (pDNAs) and ATF4-targeting shRNA (shATF4) to induce osteogenesis, chondrogenesis, and adipogenesis of human mesenchymal stem cells (hMSCs). The pDNAs and shATF4 were complexed with TRITC-gene regulation nanoparticles (GRN). Osteogenesis-related gene expression was reduced at early (12 h) and late (36 h) time points after co-delivery of shATF4 and SOX9 or C/EBPα pDNA, respectively, and osteogenesis was inhibited in these hMSCs. By contrast, osteogenesis-related genes were highly expressed upon co-delivery of RUNX2 and ATF4 pDNAs. DEX in GRN enhanced chondrogenic differentiation. Expression of osteogenesis-, chondrogenesis-, and adipogenesis-related genes was higher in hMSCs transfected with NPs complexed with RUNX2 and ATF4 pDNAs, shATF4 and SOX9 pDNA, and shATF4 and C/EBPα pDNA for 72 h than in control hMSCs, respectively. Moreover, delivery of these NPs also increased expression of osteogenesis-, chondrogenesis-, and adipogenesis-related proteins. These alterations in expression led to morphological changes, indicating that hMSCs differentiated into osteoblasts, chondrocytes, and adipose cells.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: RNA Interference and Gene Delivery · Advanced biosensing and bioanalysis techniques · MicroRNA in disease regulation

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (43)

Show source-provided references
1. Overcoming cellular barriers for RNA therapeutics10.1038/nbt.3802 ↗
2. Cross-platform DNA encoding for imaging single-cell of gene expression10.1002/anie.201603945 ↗
3. Targeted gene knockdown in early embryos using siRNA10.1007/978-1-4939-6988-3_14 ↗
4. Cellular localization of long non-coding RNAs affects silencing by RNAi more than by antisense oligonucleotides10.1093/nar/gkv1206 ↗
5. siRNA Design software for a target gene-specific RNA interference10.3389/fgene.2012.00102 ↗
6. RNAi-mediated gene silencing in tumour tissue using replication-competent retroviral vectors10.1038/gt.2011.48 ↗
7. Design and cloning of lentiviral vectors expressing small interfering RNAs10.1038/nprot.2006.36 ↗
8. A small interfering RNA targeting osteopontin as gastric cancer therapeutics10.1016/j.canlet.2008.07.004 ↗
9. Stable suppression of gene expression in murine embryonic stem cells by RNAi directed from DNA vector-based short hairpin RNA10.1634/stemcells.22-1-93 ↗
10. Small RNA: can RNA interference be exploited for therapy?10.1016/S0140-6736(03)14637-5 ↗
11. Future of rAAV gene therapy: platform for RNAi, gene editing, and beyond10.1089/hum.2016.171 ↗
12. EGF receptor targeted lipo-oligocation polyplexes for antitumoral siRNA and miRNA delivery10.1088/0957-4484/27/46/464001 ↗
13. RNA interference-based nanosystems for inflammatory bowel disease therapy10.2147/IJN.S116902 ↗
14. Highly efficient and safe delivery of VEGF siRNA by bioreducible fluorinated peptide dendrimers for cancer therapy10.1021/acsami.6b16689 ↗
15. ε-Caprolactone-Modified polyethylenimine as efficient nanocarriers for siRNA delivery in vivo10.1021/acsami.6b08542 ↗
16. Intracellular localization of nanoparticle dimers by chirality reversal10.1038/s41467-017-01337-2 ↗
17. Tuning the interactions between chiral plasmonic films and living cells10.1038/s41467-017-02268-8 ↗
18. Self assembled dual responsive micelles stabilized with protein for co-delivery of drug and siRNA in cancer therapy10.1016/j.biomaterials.2017.04.022 ↗
19. Mg(II)-Catechin nanoparticles delivering siRNA targeting EIF5A2 inhibit bladder cancer cell growth in vitro and in vivo10.1016/j.biomaterials.2015.11.022 ↗
20. Lightactivated RNA interference in human embryonic stem cells10.1016/j.biomaterials.2015.06.006 ↗
21. Controlled 3D culture in Matrigel microbeads to analyze clonal acinar development10.1016/j.biomaterials.2015.02.042 ↗
22. Sialic acid-targeted nanovectors with phenylboronic acid-grafted polyethylenimine robustly enhance sirna-based cancer therapy10.1021/acsami.5b11866 ↗
23. miR-29b-Loaded gold nanoparticles targeting to the endoplasmic reticulum for synergistic promotion of osteogenic differentiation10.1021/acsami.6b02969 ↗
24. Functional quantum dot-siRNA nanoplexes to regulate chondrogenic differentiation of mesenchymal stem cells10.1016/j.actbio.2016.09.008 ↗
25. Gold-Quantum dot core-satellite assemblies for lighting up MicroRNA
26. Dual quantification of MicroRNAs and telomerase in living cells10.1021/jacs.7b03617 ↗
27. BMP and TGF-β pathway mediators are critical upstream regulators of Wnt signaling during midbrain dopamine differentiation in human pluripotent stem cells10.1016/j.ydbio.2013.01.012 ↗
28. Alginate bead based hexagonal close packed 3D implant for bone tissue engineering10.1021/acsami.6b08512 ↗
29. Biophysical regulation of mouse embryonic stem cell fate and genomic integrity by feeder derived matrices10.1016/j.biomaterials.2016.12.006 ↗
30. Defect-related luminescent hydroxyapatite-enhanced osteogenic differentiation of bone mesenchymal stem cells via an ATP-induced cAMP/PKA pathway10.1021/acsami.6b01103 ↗
31. Effect of hydrogel elasticity and ephrinB2-immobilized manner on Runx2 expression of human mesenchymal stem cells
32. Competing roles of substrate composition, microstructure, and sustained strontium release in directing osteogenic differentiation of hMSCs10.1021/acsami.6b08694 ↗
33. ATF4 is a substrate of RSK2 and an essential regulator of osteoblasts biology: implication for coffin-lowry syndrome10.1016/S0092-8674(04)00344-7 ↗
34. MicroRNA-214 suppresses osteogenic differentiation of human periodontal ligament stem cells by targeting ATF4
35. miR-214 targets ATF4 to inhibit bone formation10.1038/nm.3026 ↗
36. Chondrocytic ATF4 regulates osteoblasts differentiation and function via Ihh10.1242/dev.069575 ↗
37. ATF4 regulates chondrocytes proliferation and differentiation during endochondral ossification by activating Ihh transcription10.1242/dev.043281 ↗
38. Vimentin inhibits ATF4-mediated osteocalcin transcription and osteoblasts differentiation
39. Inhibition of osteoblast mineralization by phosphorylated phage-derived apatite-specific peptide10.1016/j.biomaterials.2015.09.021 ↗
40. Hypertrophic differentiation during chondrogenic differentiation of progenitor cells is stimulated by BMP-2 but suppressed by BMP-710.1016/j.joca.2013.01.009 ↗
41. Migratory chondrogenic progenitor cells from repair tissue during the later stages of human osteoarthritis10.1016/j.stem.2009.01.015 ↗
42. Co-delivery of Cbfa-1-targeting siRNA and SOX9 protein using PLGA nanoparticles to induce chondrogenesis of human mesenchymal stem cells10.1016/j.biomaterials.2014.05.092 ↗
43. Co-delivery of SOX9 genes and anti-Cbfa-1 siRNA coated onto PLGA nanoparticles for chondrogenesis of human MSCs10.1016/j.biomaterials.2012.02.051 ↗